OCUL insider trading
Ocular Therapeutix, Inc
In the past 36 days, 3 insiders sold $234K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Todd Anderman Chief Legal Officer |
$87K 11,984 sh @ $7.29 |
−7.9% | Pre-scheduled | Oct 8, 2026 Filed Oct 13, 2026 |
Jeffrey S. Heier Chief Scientific Officer |
$77K 10,869 sh @ $7.05 |
−3.4% | Pre-scheduled | Oct 2, 2026 Filed Oct 6, 2026 |
Peter Kaiser Chief Development Officer |
$70K 9,990 sh @ $7.05 |
−3.8% | Pre-scheduled | Oct 2, 2026 Filed Oct 6, 2026 |